| scholarly article | Q13442814 |
| P50 | author | Jeffrey R Curtis | Q87706464 |
| Bruce H Fireman | Q90325741 | ||
| Lisa J Herrinton | Q91306296 | ||
| P2093 | author name string | G Thomas Ray | |
| Jashin J Wu | |||
| Liyan Liu | |||
| Robert Goldfien | |||
| P2860 | cites work | Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 |
| Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 | ||
| Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. | Q53725487 | ||
| Influence of biological agents on cardiovascular disease in rheumatoid arthritis | Q56969669 | ||
| Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 | ||
| Antirheumatic drug use and the risk of acute myocardial infarction | Q80016233 | ||
| Does tumor necrosis factor alpha inhibition promote or prevent heart failure in patients with rheumatoid arthritis? | Q80800883 | ||
| Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis | Q81922641 | ||
| Tumor necrosis factor α inhibitor use and decreased risk for incident coronary events in rheumatoid arthritis | Q85720945 | ||
| Republished: The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis | Q86074324 | ||
| Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration | Q30885473 | ||
| Impact of continued biased disenrollment from the Medicare Advantage Program to fee-for-service | Q33551949 | ||
| High ten-year risk of cardiovascular disease in newly diagnosed rheumatoid arthritis patients: a population-based cohort study | Q34090034 | ||
| Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research | Q34301743 | ||
| Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases | Q34439990 | ||
| Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment | Q34563216 | ||
| The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. | Q35135831 | ||
| Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans | Q35212433 | ||
| Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease | Q35377706 | ||
| Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study | Q35605663 | ||
| Disease activity in rheumatoid arthritis and the risk of cardiovascular events | Q35655764 | ||
| Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis | Q35669374 | ||
| Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis | Q36030664 | ||
| Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs | Q36361147 | ||
| Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register | Q36732112 | ||
| Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study | Q36757060 | ||
| Changing patterns of medication use in patients with rheumatoid arthritis in a Medicaid population | Q36763024 | ||
| Role of inflammation in atherosclerosis associated with rheumatoid arthritis | Q37300182 | ||
| The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37640953 | ||
| Systematic review and meta‐analysis: Anti–tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis | Q37801353 | ||
| Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review | Q37808889 | ||
| Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis | Q38465160 | ||
| An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy | Q39110166 | ||
| Confounding control in healthcare database research: challenges and potential approaches. | Q39700269 | ||
| Covered today, sick tomorrow? Trends and correlates of children's health insurance instability | Q42085378 | ||
| Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis | Q43524523 | ||
| Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study | Q44973310 | ||
| Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis | Q45129989 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 17-101 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | The Permanente Journal | Q26853956 |
| P1476 | title | An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches | |
| P478 | volume | 22 |
| Q64251395 | Assessment of Cardiovascular Disease Risk and Therapeutic Patterns among Urban Black Rheumatoid Arthritis Patients | cites work | P2860 |
Search more.